Nanotechnologic nutraceuticals: Nurturing or nefarious? [3]

Clinical Chemistry

Volumn 52, Issue 2, 2006, Pages 331-332

  Park, Jason Y ^a   Li, Sam F Y ^b   Kricka, Larry J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; GOLD; HERBACEOUS AGENT; MESOCOPPER; MESOGOLD; MESOPLATINUM; MESOSILVER; METAL; MINERAL; MOLYBDENUM; NANOPARTICLE; NUTRACEUTICAL; PALLADIUM; PLATINUM; SILVER; TITANIUM; UNCLASSIFIED DRUG; VITAMIN; ZINC;

ASSAY; BLOOD ANALYSIS; CLINICAL LABORATORY; COLLOID; DIET SUPPLEMENTATION; DRUG DELIVERY SYSTEM; HUMAN; LABORATORY TEST; LETTER; NANOTECHNOLOGY; URINALYSIS;

COLLOIDS; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; METALS; NANOTECHNOLOGY;

EID: 31844436115     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.061754     Document Type: Letter

References (5)

1. Fugh-Berman A. Alternative medicine. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 2001: 49-54.
2. Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol 1996;34:119-26.
3. Mantani N, Sakai S, Kogure T, Goto H, Shibahara N, Kita T, et al. Herbal medicine and false-positive results on lymphocyte transformation test. Yakugaku Zasshi 2002;122:399-402.
4. Purest Colloids, Inc. home page, www.purestcolloids.com (accessed December 7, 2005).
5. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001;90:1927-36.